Alexion, AstraZeneca Rare Disease - Health Care Sector

A comprehensive view of Alexion, AstraZeneca Rare Disease. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Alexion, AstraZeneca Rare Disease, completes purchase and licence agreement for early-stage rare disease gene therapy portfolio from Pfizer

Published: September 20, 2023 by AstraZeneca AB

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count

CONTACT US

We offer built-to-order industry coverage for our clients. Click on any of the markets or drivers to see a sample intelligence map or call us for a free consultation.

Call Us

310.553.0008

Email Us

info@industryintel.com

About Us

We deliver market news & information relevant to your business.

We monitor all your market drivers.

We aggregate, curate, filter and map your specific needs.

We deliver the right information to the right person at the right time.

Latest Public Posts

Client-Centric Solutions at Industry Intelligence

September 7, 2023

Information Delivery with a Vision

August 8, 2023

Saving Our Planet with Lignocellulose

April 11, 2022

Useful Links

Our Contacts

1990 S Bundy Dr. Suite #380,
Los Angeles, CA 90025

+1 (310) 553 0008

contact@industryintel.com
www.industryintel.com

About Cookies On This Site

This website stores cookies on your computer. These cookies are used to improve your website experience and provide more personalized services to you, both on this website and through other media. To find out more about the cookies we use, see our Privacy Policy. We won't track your information when you visit our site. But in order to comply with your preferences, we'll have to use just one tiny cookie so that you're not asked to make this choice again.